MaaT Pharma SA (MAAT.PA) Stock Price

€5.7 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    2

  • Technical

    5

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on MaaT Pharma SA, AI stock picks, stock alerts and much more.

Sign up

MAAT.PA AI Stock Analysis

AI stock analysis for MAAT.PA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like MaaT Pharma SA (MAAT.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

MaaT Pharma SA (MAAT.PA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of MaaT Pharma SA (MAAT.PA), currently trading at €5.7, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About MAAT.PA

LSE

  • MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors.

  • Symbol

    MAAT.PA

  • Market

    EURONEXT

  • Industry

    Biotechnology

  • Market Cap

    92M

Similar Stocks

VLA.PA Valneva SE
VLA.PA		 €5.05
2.4%
5
TUB.BR Financière de Tubize SA
TUB.BR		 €160.6
0.4%
8
OSE.PA OSE Immunotherapeutics SA
OSE.PA		 €6.32
0.5%
6
UCB.BR UCB SA
UCB.BR		 €197.3
0.9%
6
IPH.PA Innate Pharma S.A.
IPH.PA		 €2.01
1.9%
5

News

No news articles.

MAAT.PA Alternative Data

Web Traffic

MaaT Pharma SA receives an estimated 6390 monthly visitors to maatpharma.com.

  • Web Traffic

    6390

  • Change from Previous Month

    16%

  • 3 Month Change

    24.2%

  • YoY Change

    24.2%

Twitter Followers

MaaT Pharma SA has 1,564 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.6% over the last month.

  • Twitter Followers

    1564

  • Daily Change

    0.1%

  • 1 Month Change

    0.6%

  • 3 Month Change

    1.3%

  • YoY Change

    1.3%

Facebook Engagement

MaaT Pharma SA has engaged 1 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Youtube Subscribers

MaaT Pharma SA has 60 subscribers on its main Youtube channel.

  • Youtube Subscribers

    60

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Job Postings

MaaT Pharma SA currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

MaaT Pharma SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Employees

According to LinkedIn, MaaT Pharma SA has 85 employees, up by 1.2% over the last month.

  • LinkedIn Employees

    85

  • Daily Change

    1.2%

  • 1 Month Change

    1.2%

  • 3 Month Change

    0%

  • YoY Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at MaaT Pharma SA is 79 out of 100 (bullish).

  • Business Outlook

    79

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

MaaT Pharma SA was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

MAAT.PA Financials

MAAT.PA Key Metrics

  • Total Revenue

    €1.5M

  • Net Income

    -€16M

  • Earnings per Share

    -€1.15

  • Free cash flow

    -€10M

  • EBITDA

    -€16.5M

  • EBITDA Ratio

    -11.0174

  • Total Assets

    €38.5M

MAAT.PA 2-year Revenue & Income
MAAT.PA 2-year Free Cash Flow

MAAT.PA Technicals

MAAT.PA SMA
MAAT.PA RSI

FAQ

What's the current price of MaaT Pharma SA (MAAT.PA) Stock?
The price of an MaaT Pharma SA (MAAT.PA) share is €5.7.

What's the market cap of MaaT Pharma SA?
The current market cap of MaaT Pharma SA is 92M.

Should I buy or sell MAAT.PA?
MaaT Pharma SA shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, MaaT Pharma SA is better viewed as a hold or accumulate position while waiting for further developments.

Is MaaT Pharma SA a good investment?
The current analysis of MaaT Pharma SA's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in MaaT Pharma SA's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy MaaT Pharma SA (MAAT.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for MaaT Pharma SA stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to MaaT Pharma SA (MAAT.PA) that investors often compare it to?
MaaT Pharma SA (MAAT.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..

What is the forecast for MaaT Pharma SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast MaaT Pharma SA's stock price to be around €5.9 in 2026. Starting from the current price of €5.7, this represents a 3.5% change in price, indicating a neutral outlook for the stock.

How to buy MaaT Pharma SA (MAAT.PA) Stock?
MaaT Pharma SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy MaaT Pharma SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.